MMP-2 and MMP-9 protein levels have been reported to be altered in the blood, skin, and/or cerebrospinal fluid (CSF) of ALS patients or in animal models of ALS [5,6,7,8,9,10]. This evidence concerns the gene MMP9 and amyotrophic lateral sclerosis.